You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Dow
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

TINIDAZOLE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Tinidazole

A generic version of TINIDAZOLE was approved as tinidazole by HIKMA on April 30th, 2012.

  Start Trial

Drug patent expirations by year for TINIDAZOLE
Drug Prices for TINIDAZOLE

See drug prices for TINIDAZOLE

Drug Sales Revenue Trends for TINIDAZOLE

See drug sales revenues for TINIDAZOLE

Recent Clinical Trials for TINIDAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shandong UniversityPhase 4
Damascus HospitalPhase 4
Kirby InstitutePhase 4

See all TINIDAZOLE clinical trials

Pharmacology for TINIDAZOLE
Medical Subject Heading (MeSH) Categories for TINIDAZOLE

US Patents and Regulatory Information for TINIDAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Edenbridge Pharms TINIDAZOLE tinidazole TABLET;ORAL 203808-001 Aug 4, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Unique Pharm Labs TINIDAZOLE tinidazole TABLET;ORAL 202489-001 Oct 9, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma TINIDAZOLE tinidazole TABLET;ORAL 201172-002 Apr 30, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Unique Pharm Labs TINIDAZOLE tinidazole TABLET;ORAL 202489-002 Oct 9, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Edenbridge Pharms TINIDAZOLE tinidazole TABLET;ORAL 203808-002 Aug 4, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma TINIDAZOLE tinidazole TABLET;ORAL 201172-001 Apr 30, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Novel Labs Inc TINIDAZOLE tinidazole TABLET;ORAL 202044-002 Apr 30, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
McKinsey
Medtronic
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.